Skip to content
healthcare.dev

Dapagliflozin

NDC 70954-857, Dapagliflozin, tablet, film coated, from ANI Pharmaceuticals, Inc..

Product NDC
70954-857
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211156
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-857 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70954-857-107095408571030 TABLET, FILM COATED in 1 BOTTLE (70954-857-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6425d240-5dd9-4a2c-9348-f8a859702850
  • NADAC price for package 70954085710

    GET /v1/drugs/nadac/70954085710

Use it

Look up 70954-857 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-857 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-857. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.